Terms: = Lymphoma AND HSP90AA1, ENSG00000080824, 3320, P07900, LAP2, HSPN, HSPCAL4, HSPCAL1, HSPCA, HSPC1, HSP90N, HSP90A, Hsp90, Hsp89, HSP86, FLJ31884
214 results:
1. Inhibition of PRMT5/MEP50 Arginine Methyltransferase Activity Causes Cancer Vulnerability in NDRG2
Ichikawa T; Suekane A; Nakahata S; Iha H; Shimoda K; Murakami T; Morishita K
Int J Mol Sci; 2024 Feb; 25(5):. PubMed ID: 38474089
[TBL] [Abstract] [Full Text] [Related]
2. Molecular mechanism of selenium against lead-induced apoptosis in chicken brainstem relating to heat shock protein, selenoproteins, and inflammatory cytokines.
Chen D; Yu W; Hao Z; Qiu M; Cui J; Tang Y; Teng X; Liu Y; Liu H
Ecotoxicol Environ Saf; 2024 Mar; 272():116028. PubMed ID: 38310824
[TBL] [Abstract] [Full Text] [Related]
3. Bacterial heat shock protein genes during induction chemotherapy in pediatric patients with acute lymphoblastic leukemia.
Dunn KA; MacDonald E; MacDonald T; Kulkarni K
Future Oncol; 2024 Jan; 20(1):17-23. PubMed ID: 38189148
[No Abstract] [Full Text] [Related]
4. Synergistic effect of hsp90 inhibitor ginkgolic acids C15
Ma H; Huang D; Li B; Ding F; Li H; Wu C
Zhong Nan Da Xue Xue Bao Yi Xue Ban; 2023 Aug; 48(8):1128-1135. PubMed ID: 37875353
[TBL] [Abstract] [Full Text] [Related]
5. SIRT1 and hsp90α feed-forward circuit safeguards chromosome segregation integrity in diffuse large B cell lymphomas.
Białopiotrowicz-Data E; Noyszewska-Kania M; Jabłońska E; Sewastianik T; Komar D; Dębek S; Garbicz F; Wojtas M; Szydłowski M; Polak A; Górniak P; Juszczyński P
Cell Death Dis; 2023 Oct; 14(10):667. PubMed ID: 37816710
[TBL] [Abstract] [Full Text] [Related]
6. BIIB021, an orally available and small-molecule inhibitor of hsp90, activates intrinsic apoptotic pathway in human cervical adenocarcinoma cell line (HeLa).
Güven CM; Özgür A
Eur Rev Med Pharmacol Sci; 2023 Aug; 27(15):7299-7308. PubMed ID: 37606138
[TBL] [Abstract] [Full Text] [Related]
7. Cytokine-Induced Killer Cells in Combination with Heat Shock Protein 90 Inhibitors Functioning via the Fas/FasL Axis Provides Rationale for a Potential Clinical Benefit in Burkitt's lymphoma.
Ge F; Wang Y; Sharma A; Yang Y; Liu H; Essler M; Jaehde U; Schmidt-Wolf IGH
Int J Mol Sci; 2023 Aug; 24(15):. PubMed ID: 37569852
[TBL] [Abstract] [Full Text] [Related]
8. A Coumarin-Imidazothiadiazole Derivative, SP11 Abrogates Tumor Growth by Targeting hsp90 and Its Client Proteins.
Nirgude S; Shahana M V ; Ravindran F; Kumar S; Sharma S; Mahadeva R; Mhatre A; Karki SS; Choudhary B
Molecules; 2023 Jul; 28(13):. PubMed ID: 37446888
[TBL] [Abstract] [Full Text] [Related]
9. The effects of STA-9090 (Ganetespib) and venetoclax (ABT-199) combination on apoptotic pathways in human cervical cancer cells.
Karademir D; Özgür A
Med Oncol; 2023 Jul; 40(8):234. PubMed ID: 37432531
[TBL] [Abstract] [Full Text] [Related]
10. [Molecular mechanism of ginsenoside Rg_1 against radiation enteritis: based on network pharmacology and in vitro experiment].
Wang YG; Dou YQ; Yan ZQ; Gao Y
Zhongguo Zhong Yao Za Zhi; 2023 May; 48(10):2810-2819. PubMed ID: 37282941
[TBL] [Abstract] [Full Text] [Related]
11. Heat shock factor 1 is a promising therapeutic target against adult T-cell leukemia.
Ishikawa C; Mori N
Med Oncol; 2023 May; 40(6):172. PubMed ID: 37165174
[TBL] [Abstract] [Full Text] [Related]
12. EML4-ALK biology and drug resistance in non-small cell lung cancer: a new phase of discoveries.
Elshatlawy M; Sampson J; Clarke K; Bayliss R
Mol Oncol; 2023 Jun; 17(6):950-963. PubMed ID: 37149843
[TBL] [Abstract] [Full Text] [Related]
13. HSPs/STAT3 Interplay Sustains DDR and Promotes Cytokine Release by Primary Effusion lymphoma Cells.
Gonnella R; Arena A; Zarrella R; Gilardini Montani MS; Santarelli R; Cirone M
Int J Mol Sci; 2023 Feb; 24(4):. PubMed ID: 36835344
[TBL] [Abstract] [Full Text] [Related]
14. Activation of hsp90/HSF1 Signaling as an Adaptive Response to an Electrophilic Metabolite of Morphine.
Matsuo K; Abiko Y; Yamano S; Matsusue K; Kumagai Y
Biol Pharm Bull; 2023; 46(2):334-337. PubMed ID: 36724961
[TBL] [Abstract] [Full Text] [Related]
15. Aberrant hsp90 Expression in Lymphocytes and hsp90 Response to Anti-PD-1 Therapy in lymphoma Patients.
Albakova Z; Mangasarova Y; Albakov A; Nikulina E; Kravchenko S; Sapozhnikov A
Front Immunol; 2022; 13():893137. PubMed ID: 35572591
[TBL] [Abstract] [Full Text] [Related]
16.
Manunu B; Serafin AM; Akudugu JM
Int J Radiat Biol; 2023; 99(2):292-307. PubMed ID: 35511481
[TBL] [Abstract] [Full Text] [Related]
17. RNA-seq and integrated network analysis reveals the hub genes and key pathway of paclitaxel inhibition on Adriamycin resistant diffuse large B cell lymphoma cells.
Hong H; Luo B; Qin Y; Li S; Peng Z
Bioengineered; 2022 Mar; 13(3):7607-7621. PubMed ID: 35263200
[TBL] [Abstract] [Full Text] [Related]
18. hsp90 inhibition sensitizes DLBCL cells to cisplatin.
Schmidt L; Issa II; Haraldsdóttir H; Hald JL; Schmitz A; Due H; Dybkær K
Cancer Chemother Pharmacol; 2022 Apr; 89(4):431-440. PubMed ID: 35190872
[TBL] [Abstract] [Full Text] [Related]
19. [The Relationship between PPP2R5C and Molt-4 Cell Viability, hsp90-GR Signal in Childhood Acute T Lymphocytic Leukemia].
Liu L; Li HT; Zheng HY; Dang HB
Zhongguo Shi Yan Xue Ye Xue Za Zhi; 2022 Feb; 30(1):84-91. PubMed ID: 35123608
[TBL] [Abstract] [Full Text] [Related]
20. Inhibition of adult T-cell leukemia cell proliferation by polymerized proanthocyanidin from blueberry leaves through JAK proteolysis.
Ichikawa T; Sugamoto K; Matsuura Y; Kunitake H; Shimoda K; Morishita K
Cancer Sci; 2022 Apr; 113(4):1406-1416. PubMed ID: 35100463
[TBL] [Abstract] [Full Text] [Related]
[Next]
